Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

about

Evaluation of the combination of the dual m-TORC1/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models.

P2860

Q49393542-91E9BA62-5308-4B2B-A25E-33ABA95F57BE

P2860

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

Item

http://www.wikidata.org/entity/Q35953034

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

@ast

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

@en

type

Item

label

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

@ast

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

@en

prefLabel

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

@ast

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

@en

P1476

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

@en

P2093

Antonis Koussounadis

http://www.w3.org/2001/XMLSchema#string

Charlene Kay

http://www.w3.org/2001/XMLSchema#string

Inhwa Um

http://www.w3.org/2001/XMLSchema#string

Kyle E Francis

http://www.w3.org/2001/XMLSchema#string

Simon P Langdon

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

Integrated genomic analyses of ovarian carcinoma

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

Cancer genes and the pathways they control

CHEK again: revisiting the development of CHK1 inhibitors for cancer therapy

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

Pathway and network analysis of cancer genomes

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

MAP kinase signalling pathways in cancer

STATs in oncogenesis

P2888

s12885-016-2212-6

P304

205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-016-2212-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

David J Harrison

V Anne Smith

P577

2016-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297753307

http://www.w3.org/2001/XMLSchema#string

P6179

1038543737

http://www.w3.org/2001/XMLSchema#string

P698

26964739

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

4787009

http://www.w3.org/2001/XMLSchema#string

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

about

P2860

P2860

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P921

P932